Full View

In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii

I Karaoglan, Y Zer, VK Bosnak… - Journal of …, 2013 - journals.sagepub.com
Objective Nosocomial infection caused by carbapenem-resistant Acinetobacter baumannii is
a worldwide problem and treatment options remain controversial. This study investigated the …
被引用次数：60 相关文章

In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii …

I Karaoglan, Y Zer, VK Bosnak, AO Mete, M Namıduru - 2013 - cabidigitallibrary.org
Objective: Nosocomial infection caused by carbapenem-resistant Acinetobacter baumannii
is a worldwide problem and treatment options remain controversial. This study investigated …

In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.

I Karaoglan, Y Zer, VK Bosnak, AO Mete… - The Journal of …, 2013 - europepmc.org
Objective Nosocomial infection caused by carbapenem-resistant Acinetobacter baumannii is
a worldwide problem and treatment options remain controversial. This study investigated the …
[PDF] academia.edu

[PDF][PDF] Ilkay Karaoglan1, Yasemin Zer2, Vuslat Kecik Bosnak1, Ayse Ozlem Mete1 and

M Namıduru - Journal of International Medical Research - academia.edu
Objective: Nosocomial infection caused by carbapenem-resistant Acinetobacter baumannii
is a worldwide problem and treatment options remain controversial. This study investigated …

[引用][C] In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter …

I KARAOGLAN, Y ZER, VK BOSNAK… - Journal of …, 2013 - pascal-francis.inist.fr
In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/ β-lactamase inhibitor
combinations against carbapenem-resistant Acinetobacter baumannii CNRS Inist …
[PDF] cyberleninka.org

[PDF][PDF] Ilkay Karaoglan1, Yasemin Zer2, Vuslat Kecik Bosnak1, Ayse Ozlem Mete1 and

M Namıduru - Journal of International Medical Research - cyberleninka.org
Objective: Nosocomial infection caused by carbapenem-resistant Acinetobacter baumannii
is a worldwide problem and treatment options remain controversial. This study investigated …

In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii

I Karaoglan, Y Zer, VK Bosnak… - The Journal of …, 2013 - pubmed.ncbi.nlm.nih.gov
Objective Nosocomial infection caused by carbapenem-resistant Acinetobacter baumannii is
a worldwide problem and treatment options remain controversial. This study investigated the …

[引用][C] In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic

I KARAOGLAN, Y ZER, VK BOSNAK… - Journal of …, 2013 - Sage Publications